Controversy and debate on dengue vaccine series—paper 3: final response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs
- 1 March 2018
- journal article
- editorial
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 95, 142
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Controversy and debate on dengue vaccine series—paper 2: response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programsJournal of Clinical Epidemiology, 2018
- Controversy and debate on dengue vaccine series—paper 1: review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programsJournal of Clinical Epidemiology, 2018
- Dengue Vaccine Efficacy: Not a Zero Sum GameThe Journal of Infectious Diseases, 2016
- Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forwardVaccine, 2015
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic DiseaseNew England Journal of Medicine, 2015